Topic
Explore the latest artificial intelligence news and research.
A report claims Apple is considering an enterprise AI server with multiple M8 Ultra chips and NVIDIA's NVLink Fusion. We examine the claim against Apple's current Mac clusters, Private Cloud Compute, and NVIDIA's official materials.
Google has launched early access to Home MCP in the US. Drawing on primary sources, we examine how external AI agents can access home device data and history, and the safety boundaries in place, including a ban on unlocking doors and requirements for additional consent.
Mozilla's partnership with Mistral brings Mistral Small 4 to Smart Window. Here's how the three-model choice, cloud inference, proxy protection, and memory storage actually work.
Anthropic is merging Claude Chat and Cowork into a single experience. Based on primary sources, we break down how this differs from July's shared home update, what Docs and Slides bring, and which boundaries—permissions, usage, and devices—still remain.
An anonymous leak claims next-gen GeForce, including an RTX 6090, is targeting early 2027. We examine that claim against NVIDIA's official launch cadence, Rubin architecture specs, and its supply and revenue disclosures.
Perplexity's local AI agent now supports Windows. We look at its on-device runtime design, the 24GB VRAM requirement, and where local processing ends when cloud services are involved.
TypeSafe has released Jev, a decision-only AI that returns choices and probabilities in parallel rather than writing prose. How does it differ from conventional LLMs? We examine RLCD, structured outputs, what confidence means, and the conditions behind the speed claims, drawing on official specs and third-party trials.
Simply publishing an AI model's weights doesn't make it open source. Without training data or auditable records to verify and reproduce results, that boundary remains undefined—and the OpenMDW license, which aims to codify it, still hasn't cleared OSI review over its termination clause.
A Mozilla study finds that the performance gap between commercial AI models and open-weight models—led largely by Chinese developers—has narrowed to 4.4 months. A 5x cost premium is increasingly justified only for a narrow band of difficult tasks that take human experts 8 to 12 hours to complete.
Insilico's 'Longevity Vaccine' is a research concept that temporarily reprograms T-cells in the body using circular RNA. By cross-referencing prior mouse studies and a Phase 1 trial, this article separates the proven components from the undisclosed targets and safety data.
